Connect with us
The Red Cross's second-ever blood crisis follows 2022 reforms that fixed hospital scheduling but never reached the aging donor pool now driving a four-year.
An FDA panel recommended six peptides, including BPC-157, for pharmacy use, lifting Hims stock 13% even as pricing and enforcement gaps suggest the gray market.
China's new domestic lithography machines and CXMT's blockbuster IPO show how years of US export controls fueled the competition now hitting Sandisk and ASML.
A second Canadian shipment missed the same US border check within a day of Maple Leaf's bacon recall, weeks before 50% tariffs begin.